Assay Health 

Bioanalytical Assay Development and Validation for SARS-CoV-2 therapeutics

Today effective therapies and prophylactic vaccines are the need of time for severe acute respiratory syndrome coronavirus (2 SARS-CoV-2). Bioanalytical assays, hplc analysis, and bioanalytical methods must efficiently characterize the efficacy and safety of SARS-CoV-2 therapeutics. Nevertheless, repurposed therapies need to be tested with new assays specific for SARS-CoV-2.  The current pandemic has increased the demand for human sample assays capable of detecting antibodies, biomarkers, and therapeutic responses in patients, and in vitro assays showing neutralization of the virus. Notably, it is crucial to understand that the components of the…

Read More
Follow by Email